Log In
Print
BCIQ
Print
Print this Print this
 

LymPro Test

  Manage Alerts
Collapse Summary General Information
Company Memory Dx LLC
DescriptionMeasure CD69 presentations at the surface in peripheral blood lymphocytes (PBLs) with and without mitogenic stimulation
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPilot
Standard IndicationNeurology, Diagnostic
Indication DetailsDiagnose chronic traumatic encephalopathy; Diagnose mild to moderate Alzheimer's disease (AD); Diagnose moderate and severe Alzheimer's disease (AD); Early diagnosis of Alzheimer's disease (AD)
Regulatory Designation
Partner Amarantus BioScience Holdings Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

$1.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today